×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TCRX – tscan therapeutics, inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TCRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/5
08:52 am
tcrx
TScan Therapeutics (TCRX) had its price target raised by Wedbush from $4.00 to $5.00. They now have an "outperform" rating on the stock.
Medium
Report
TScan Therapeutics (TCRX) had its price target raised by Wedbush from $4.00 to $5.00. They now have an "outperform" rating on the stock.
3/4
07:25 am
tcrx
TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
3/4
07:00 am
tcrx
TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Medium
Report
TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
2/26
07:09 am
tcrx
TScan Therapeutics Completes Enrollment in Cohort C of Phase 1 ALLOHA™ Trial and Announces FDA Clearance of Investigational New Drug Applications for Heme Candidates TSC-102-A01 and TSC-102-A03 [Yahoo! Finance]
Neutral
Report
TScan Therapeutics Completes Enrollment in Cohort C of Phase 1 ALLOHA™ Trial and Announces FDA Clearance of Investigational New Drug Applications for Heme Candidates TSC-102-A01 and TSC-102-A03 [Yahoo! Finance]
2/26
07:00 am
tcrx
TScan Therapeutics Completes Enrollment in Cohort C of Phase 1 ALLOHA™ Trial and Announces FDA Clearance of Investigational New Drug Applications for Heme Candidates TSC-102-A01 and TSC-102-A03
Low
Report
TScan Therapeutics Completes Enrollment in Cohort C of Phase 1 ALLOHA™ Trial and Announces FDA Clearance of Investigational New Drug Applications for Heme Candidates TSC-102-A01 and TSC-102-A03
2/25
07:18 am
tcrx
TScan Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
Medium
Report
TScan Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
2/25
07:00 am
tcrx
TScan Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
Low
Report
TScan Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
1/24
05:10 am
tcrx
TScan Therapeutics (NASDAQ:TCRX) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Medium
Report
TScan Therapeutics (NASDAQ:TCRX) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Date
Time
Symbol
Company Name
Action
%Chg
8/12/2025
07:00 am
TCRX
tscan therapeutics, inc.
IN-LINE
Report
3.8%
tscan therapeutics, inc.
Date
Time
Symbol
Headline
Impact
3/4
07:42 am
tcrx
Form S-8 TScan Therapeutics, Inc.
Medium
Report
Form S-8 TScan Therapeutics, Inc.
3/4
07:31 am
tcrx
Form 10-K TScan Therapeutics, Inc. For: Dec 31
Medium
Report
Form 10-K TScan Therapeutics, Inc. For: Dec 31
3/4
07:16 am
tcrx
Form 8-K TScan Therapeutics, Inc. For: Mar 04
Medium
Report
Form 8-K TScan Therapeutics, Inc. For: Mar 04
1/22
05:52 pm
tcrx
Form 4 TScan Therapeutics, Inc. For: Jan 20 Filed by: Amello Jason
Low
Report
Form 4 TScan Therapeutics, Inc. For: Jan 20 Filed by: Amello Jason
1/22
05:49 pm
tcrx
Form 4 TScan Therapeutics, Inc. For: Jan 20 Filed by: MacBeath Gavin
Low
Report
Form 4 TScan Therapeutics, Inc. For: Jan 20 Filed by: MacBeath Gavin
1/22
05:30 pm
tcrx
Form 4 TScan Therapeutics, Inc. For: Jan 20 Filed by: Dworak Leiden
Medium
Report
Form 4 TScan Therapeutics, Inc. For: Jan 20 Filed by: Dworak Leiden
1/22
05:28 pm
tcrx
Form 4 TScan Therapeutics, Inc. For: Jan 20 Filed by: Louis Chrystal
Medium
Report
Form 4 TScan Therapeutics, Inc. For: Jan 20 Filed by: Louis Chrystal
1/22
05:20 pm
tcrx
Form 4 TScan Therapeutics, Inc. For: Jan 20 Filed by: ZDRAVESKI ZORAN
Medium
Report
Form 4 TScan Therapeutics, Inc. For: Jan 20 Filed by: ZDRAVESKI ZORAN
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: